In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys

P Butaye; R Ducatelle; P De Backer; H Vermeersch; J P Remon; F Haesebrouck

doi:10.1128/AAC.41.12.2800

In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys

Antimicrob Agents Chemother. 1997 Dec;41(12):2800-1. doi: 10.1128/AAC.41.12.2800.

Authors

P Butaye¹, R Ducatelle, P De Backer, H Vermeersch, J P Remon, F Haesebrouck

Affiliation

¹ Department of Pathology, Bacteriology and Avian Diseases, University of Ghent, Belgium. pbutaye@allserv.rug.ac.be

Abstract

The in vitro susceptibility of 14 European Chlamydia psittaci strains from turkeys to the antibiotics doxycycline and enrofloxacin was tested. For doxycycline the MIC ranged from 0.05 to 0.2 microg/ml, with an average of 0.1 microg/ml. For enrofloxacin the MIC was 0.25 microg/ml. Acquired resistance was not detected against doxycycline and enrofloxacin.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Anti-Bacterial Agents / pharmacology*
Anti-Infective Agents / pharmacology*
Chlamydia Infections / veterinary*
Chlamydophila psittaci / drug effects*
Chlorocebus aethiops
Doxycycline / pharmacology*
Enrofloxacin
Europe
Fluoroquinolones*
Microbial Sensitivity Tests
Poultry Diseases / microbiology*
Quinolones / pharmacology*
Turkeys

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Fluoroquinolones
Quinolones
Enrofloxacin
Doxycycline